Health and Fitness Health and Fitness
Thu, December 22, 2011
[ Thu, Dec 22nd 2011 ] - Market Wire
SecureAlert Inc. Announces Contract to Monitor Juvenile Offenders in Clark County, Nevada
[ Thu, Dec 22nd 2011 ] - Market Wire
ARCA biopharma Announces Private Placement of $1.75 Million with Institutional Investors
[ Thu, Dec 22nd 2011 ] - Market Wire
Synageva BioPharma Completes Enrollment in Phase .. 2 for Late Onset LAL Deficiency and Announces Oth
[ Thu, Dec 22nd 2011 ] - Market Wire
Pfizer Reports Results From Three Phase 4 Studies .. ne sulfate and naltrexone hydrochloride) Extended
[ Thu, Dec 22nd 2011 ] - Market Wire
Poniard Pharmaceuticals and Allozyne Terminate Planned Merger
[ Thu, Dec 22nd 2011 ] - Market Wire
Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
[ Thu, Dec 22nd 2011 ] - Market Wire
Sucampo Reports Conclusion of Arbitration Hearing
[ Thu, Dec 22nd 2011 ] - Market Wire
Valeant Pharmaceuticals Completes Acquisition of iNova
[ Thu, Dec 22nd 2011 ] - Market Wire
Curis Announces Collaborator Rocheas Submission o .. lication for Vismodegib in Advanced Basal Cell Ca
[ Thu, Dec 22nd 2011 ] - Market Wire
AVEO Announces Patient Enrollment in Phase 2 Clin .. mbination with mFOLFOX6 in Patients with Advanced
Wed, December 21, 2011
[ Wed, Dec 21st 2011 ] - Market Wire
LabCorp Enters into New Credit Facility Totaling $1.0 Billion
[ Wed, Dec 21st 2011 ] - Market Wire
Alliance HealthCare Services Reaffirms 2011 Guida .. e and Announces Full Year 2012 Financial Guidance
[ Wed, Dec 21st 2011 ] - Market Wire
HealthSouth Announces Date of 2011 Fourth Quarter Earnings Conference Call
[ Wed, Dec 21st 2011 ] - Market Wire
SANUWAVE Updates on FDA Review of dermaPACE Premarket Approval Application
[ Wed, Dec 21st 2011 ] - Market Wire
Santarus Adds FENOGLIDE to Marketed Products Portfolio
[ Wed, Dec 21st 2011 ] - Market Wire
Transcept Pharmaceuticals Receives $10 Million Mi .. or Listing of Intermezzo Formulation Patents in F
[ Wed, Dec 21st 2011 ] - Market Wire
VIVUS Reports Topline Findings From FORTRESS
[ Wed, Dec 21st 2011 ] - Market Wire
Anika Therapeutics Announces U.S. MONOVISC License and Supply Agreement with DePuy Mitek, Inc.
[ Wed, Dec 21st 2011 ] - Market Wire
New VIP Program Makes It Easier to Join Reliv
[ Wed, Dec 21st 2011 ] - Market Wire
Emergent BioSolutions Announces Fuad El-Hibri to .. cutive Chairman of the Board of Directors Focused
[ Wed, Dec 21st 2011 ] - Market Wire
St. Jude Medical Launches Riata Communication Website
[ Wed, Dec 21st 2011 ] - Market Wire
Response Genetics, Inc. to Offer FDA-Approved ALK Test for metastatic NSCLC
[ Wed, Dec 21st 2011 ] - Market Wire
Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
[ Wed, Dec 21st 2011 ] - Market Wire
Merck and the ADAP Crisis Task Force Announce New .. nt to Improve Access and Care for People with HIV
[ Wed, Dec 21st 2011 ] - Market Wire
Cannabis Science Brand Releases Worldwide Growth .. For Its Formulations Targeting Critical Ailments
[ Wed, Dec 21st 2011 ] - Market Wire
Neogen Corporation Announces 2nd Quarter Results Conference Call
[ Wed, Dec 21st 2011 ] - Market Wire
Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS
[ Wed, Dec 21st 2011 ] - Market Wire
Catasys Raises Approximately $1 Million in Registered Direct Offering
[ Wed, Dec 21st 2011 ] - Market Wire
PharmStar Pharmaceuticals Announces Aquaprin Marketing Campaign
[ Wed, Dec 21st 2011 ] - Market Wire
Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference

Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference


Published on 2011-12-21 06:25:55 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 30th Annual J.P. Morgan Health Care Conference on Tuesday, January 10, 2012, at 2:30 p.m. (PT) or 5:30 p.m. (ET).

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through February 9, 2012.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources